Investigational seltorexant improved symptoms of major depressive disorder (MDD) and insomnia in people with an inadequate ...

The app, called Rejoyn, is cleared as a supplement to currently approved therapies and works by using specifically designed ...

Addition of the antipsychotic lumateperone (Caplyta) to an existing antidepressant improved symptoms of depression in a ...

especially treatment-resistant depression. Of the nearly 9 million people with major depression in the United States who have ...

David Walt, the Hansjörg Wyss Professor of Bioinspired Engineering at HMS and professor of pathology at Brigham and Women’s Hospital, is operating at a microscopic level, observing cell abnormalities ...

Patients with non-seasonal depression who were treated with bright light therapy reported a 40% remission rate, according to a recent study.

Researchers found that a 10-week course of home-based transcranial direct current stimulation (tDCS) significantly improved ...

Mind Medicine (MindMed) Inc. is advancing MM-120 for GAD with two phase 3 trials, VOYAGE and PANORAMA, starting in late 2024 ...

This study highlights the efficacy of home-based tDCS in treating major depressive disorder, with significant improvements in ...

If you’re feeling depressed and looking for a solution, there are many options: medications, CBT, DBT, somatic therapy and so ...

Bipolar disorder is a long-term mood disorder characterized by major fluctuations in mood — both high and low — that can ...

Patients with comorbid depression and insomnia do not feel satisfied by their health care providers or available treatment options.